Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.245 USD | -3.49% | -10.87% | +205.97% |
Sales 2024 * | 523K 719K | Sales 2025 * | 321K 442K | Capitalization | 870M 1.2B |
---|---|---|---|---|---|
Net income 2024 * | -54M -74.23M | Net income 2025 * | -64M -87.98M | EV / Sales 2024 * | 1,663 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2,706 x |
P/E ratio 2024 * |
-13.1
x | P/E ratio 2025 * |
-11.9
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.45% |
Latest transcript on Perspective Therapeutics, Inc.
1 day | -3.49% | ||
1 week | -10.87% | ||
Current month | -10.87% | ||
1 month | -33.15% | ||
3 months | +16.04% | ||
6 months | +381.41% | ||
Current year | +205.97% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 52 | 23-02-02 |
Mark Austin
DFI | Director of Finance/CFO | 37 | 17-06-30 |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 23-02-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 23-05-31 |
Lori Woods
CHM | Chairman | 61 | 23-02-02 |
Director/Board Member | 58 | 23-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.23 | -4.65% | 1 974 359 |
24-06-06 | 1.29 | -8.51% | 6,534,527 |
24-06-05 | 1.41 | +2.17% | 4,157,272 |
24-06-04 | 1.38 | +0.73% | 8,078,992 |
24-06-03 | 1.37 | -0.72% | 7,108,934 |
Delayed Quote Nyse, June 07, 2024 at 01:08 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+205.97% | 870M | |
+53.86% | 59.28B | |
+41.42% | 40.94B | |
-5.43% | 40.17B | |
-5.16% | 28.69B | |
+12.49% | 26.63B | |
-20.89% | 18.89B | |
+30.84% | 12.46B | |
+0.12% | 12.42B | |
+26.49% | 12.26B |
- Stock Market
- Equities
- CATX Stock